| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |